MedTrace Logo

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

NCT00533572 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2015-05-27

No results posted yet for this study

Summary

Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe inherited blistering skin disease caused by absence of type VII collagen. Patients with RDEB develop large, severly painful blisters and open wounds from minor trauma to their skin. In the future, we hope to start a gene transfer study on a specific group of RDEB subjects and we are screening subjects for that potential trial now.

Conditions

  • Epidermolysis Bullosa Dystrophica

Sponsors & Collaborators

Principal Investigators

  • Alfred T Lane · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533572 on ClinicalTrials.gov